Literature DB >> 17000947

Long-term survival in elderly patients hospitalized for heart failure: 14-year follow-up from a prospective randomized trial.

Bao C Huynh1, Aleksandr Rovner, Michael W Rich.   

Abstract

BACKGROUND: The growing heart failure epidemic imposes a substantial burden on the US health care system. The ability to accurately assess prognosis would allow clinicians to triage patients to appropriate therapy and to plan the intensity of care following hospital discharge.
METHODS: A cohort of 282 elderly (mean +/- SD age, 79.2 +/- 6.1 years) patients with heart failure were followed for up to 14 years after enrollment in a prospective randomized multidisciplinary disease management trial conducted from 1990 through 1994. Kaplan-Meier survival curves were constructed to assess the probability of survival during the follow-up period. A Cox proportional hazards model was developed to identify independent predictors of long-term survival. C statistics were calculated to assess the utility of the model for predicting mortality at 6 months, 1 year, and 5 years.
RESULTS: During the 14-year follow-up period, 269 patients (95%) died and the median survival was 894 days. Cox analysis identified 7 variables that were independent predictors of shorter survival time: older age (hazard ratio [HR], 1.14 per 5 years; 95% confidence interval [CI], 1.03-1.26), serum sodium level less than 135 mEq/L (HR, 1.67; 95% CI, 1.19-2.32), coronary artery disease (HR 1.51; 95% CI, 1.16-1.95), dementia (HR, 2.02; 95% CI, 1.13-3.61), peripheral vascular disease (HR, 1.74; 95% CI, 1.20-2.52), systolic blood pressure (HR, 0.95 per 10 mm Hg; 95% CI, 0.92-0.98), and serum urea nitrogen level (HR, 1.20 per 10 mg/dL [3.57 mmol/L]; 95% CI, 1.12-1.29). C statistics for the model were 0.84, 0.79, and 0.75 at 6 months, 1 year, and 5 years, respectively. A risk score for mortality was developed using the 7 independent predictor variables. One-year mortality rates among patients with 0 to 1 (n = 89), 2 to 3 (n = 153), and 4 or more (n = 37) risk factors were 9.0%, 22.2%, and 73.0%, respectively (P<.001).
CONCLUSIONS: Among elderly patients hospitalized with heart failure, median survival is about 2.5 years. However, there is considerable heterogeneity in survival, with 25% of patients dying within 1 year and 25% surviving for more than 5 years. A simple 7-item risk score, based on data readily available at the time of admission, provides a reliable estimate of prognosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17000947     DOI: 10.1001/archinte.166.17.1892

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  16 in total

1.  Effects of combined aging and heart failure on visceral sympathetic nerve and cardiovascular responses to progressive hyperthermia in F344 rats.

Authors:  M L Margiocco; M Borgarelli; T I Musch; D M Hirai; K S Hageman; R J Fels; A A Garcia; M J Kenney
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-09-15       Impact factor: 3.619

2.  The relationship between systolic blood pressure on admission and mortality in older patients with heart failure.

Authors:  María T Vidán; Héctor Bueno; Yongfei Wang; Geoffrey Schreiner; Joseph S Ross; Jersey Chen; Harlan M Krumholz
Journal:  Eur J Heart Fail       Date:  2010-02       Impact factor: 15.534

3.  Event-free survival in adults with heart failure who engage in self-care management.

Authors:  Christopher S Lee; Debra K Moser; Terry A Lennie; Barbara Riegel
Journal:  Heart Lung       Date:  2010-04-08       Impact factor: 2.210

4.  Pharmacotherapy Use in Older Patients With Heart Failure and Reduced Ejection Fraction After a Skilled Nursing Facility Stay.

Authors:  Lin Li; Bill M Jesdale; Anne Hume; Giovanni Gambassi; Robert J Goldberg; Kate L Lapane
Journal:  J Card Fail       Date:  2017-09-20       Impact factor: 5.712

Review 5.  Palliative care and hospice in advanced heart failure.

Authors:  Lisa Lemond; Larry A Allen
Journal:  Prog Cardiovasc Dis       Date:  2011 Sep-Oct       Impact factor: 8.194

6.  Clinical features, treatment practices, and hospital and long-term outcomes of older patients hospitalized with decompensated heart failure: The Worcester Heart Failure Study.

Authors:  Jane S Saczynski; Chad E Darling; Frederick A Spencer; Darleen Lessard; Joel M Gore; Robert J Goldberg
Journal:  J Am Geriatr Soc       Date:  2009-08-13       Impact factor: 5.562

Review 7.  Prognostic and Therapeutic Implications of Frailty in Older Adults with Heart Failure.

Authors:  Michael Goldfarb; Richard Sheppard; Jonathan Afilalo
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

8.  Rationale and methods of the multicenter randomised trial of a heart failure management programme among geriatric patients (HF-Geriatrics).

Authors:  Carlos Rodríguez Pascual; Emilio Paredes Galán; Jose Luis Gonzalez Guerrero; Rocio Menendez Colino; Pedro Abizanda Soler; Mercedes Hornillos Calvo; Juan Jose Solano Jaurieta; Jorge Manzarbeitia Arambarri; Jose Manuel Ribera Casado; Fernando Rodríguez-Artalejo
Journal:  BMC Public Health       Date:  2011-08-05       Impact factor: 3.295

9.  Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial.

Authors:  Alain Cohen-Solal; Dipak Kotecha; Dirk J van Veldhuisen; Daphne Babalis; Michael Böhm; Andrew J Coats; Michael Roughton; Philip Poole-Wilson; Luigi Tavazzi; Marcus Flather
Journal:  Eur J Heart Fail       Date:  2009-08-01       Impact factor: 15.534

10.  Secular trends in the etiology and comorbidity of hospitalized patients with congestive heart failure: A single-center retrospective study.

Authors:  Zhi-Yong Pei; Yu-Sheng Zhao; Jia-Yue Li; Qiao Xue; Lei Gao; Shi-Wen Wang
Journal:  J Geriatr Cardiol       Date:  2012-12       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.